Protalix BioTherapeutics, Inc. Employee Count
The employee counts Protalix BioTherapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 226; Filing 2026-03-18; Lease expense per employee $8,030.97.
- 2023-12-31: Employees (as filed) 208; Filing 2024-03-14; Lease expense per employee $7,072.12.
- 2022-12-31: Employees (as filed) 197; Filing 2023-02-27; Lease expense per employee $7,096.45.
- 2021-12-31: Employees (as filed) 206; Filing 2022-03-31; Lease expense per employee $7,922.33.
- Available history
- 2008-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 226 full-time | 2026-03-18 | $8,030.97 operating |
| 2023-12-31 | 208 full-time | 2024-03-14 | $7,072.12 operating |
| 2022-12-31 | 197 full-time | 2023-02-27 | $7,096.45 operating |
| 2021-12-31 | 206 full-time | 2022-03-31 | $7,922.33 operating |
| 2020-12-31 | 207 | 2021-03-30 | $6,676.33 operating |
| 2019-12-31 | 196 | 2020-03-12 | $6,219.39 operating |
| 2018-12-31 | 184 | 2019-03-18 | $7,608.70 rent expense, net |
| 2017-12-31 | 190 | 2018-03-06 | |
| 2016-12-31 | 232 | 2017-03-16 | |
| 2015-12-31 | 223 | 2016-03-08 | |
| 2014-12-31 | 234 | 2015-03-12 | |
| 2013-12-31 | 260 | 2014-03-13 | |
| 2012-12-31 | 266 | 2013-02-28 | |
| 2011-12-31 | 235 | 2012-02-27 | |
| 2010-12-31 | 240 | 2011-02-23 | |
| 2009-12-31 | 182 | 2010-02-26 | |
| 2008-12-31 | 138 | 2009-03-06 |
Headcount breakdown as filed
| Fiscal year end | Employees | Xbrl:Range | Filing |
|---|---|---|---|
| 2025-12-31 | 226 full-time | Maximum: 15 | 2026-03-18 “As of December 31, 2025, we had 226 employees, all of whom are full time employees, and of which 25 have a Ph.D. or an M.D. in their respective scientific fields.” |
| 2024-12-31 | Maximum: 10 | 2025-03-17 “” |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |